275
Participants
Start Date
July 31, 2022
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2026
ActiveMatrix
All patients will receive weight based prophylactic antibiotics i.e. Ancef, vancomycin, or clindamycin. Drains will be used in fusion cases only. Intrawound vancomycin will be used for all instrumented cases.No negative pressure devices will be used. Anatomic layers will be closed in similar, standard fashion for all cases. For those randomized to the treatment group, the ActiveMatrix product will be administered on top of the dura mater and again on the closed fascia. Those in the control group, will forgo this step.
Skye Biologics Holdings, LLC
INDUSTRY
Baylor College of Medicine
OTHER